TRIENTINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trientine Hydrochloride, and what generic alternatives are available?
Trientine Hydrochloride is a drug marketed by Accord Hlthcare, Amneal, Chartwell Rx, Dr Reddys, Eci Pharms Llc, Endo Operations, Hetero Labs Ltd Iii, Lupin Ltd, MSN, Navinta Llc, Rising, Watson Labs Teva, and Zydus Pharms. and is included in thirteen NDAs.
The generic ingredient in TRIENTINE HYDROCHLORIDE is trientine hydrochloride. There are ten drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trientine Hydrochloride
A generic version of TRIENTINE HYDROCHLORIDE was approved as trientine hydrochloride by WATSON LABS TEVA on February 7th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIENTINE HYDROCHLORIDE?
- What are the global sales for TRIENTINE HYDROCHLORIDE?
- What is Average Wholesale Price for TRIENTINE HYDROCHLORIDE?
Summary for TRIENTINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 13 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 13 |
| Patent Applications: | 211 |
| What excipients (inactive ingredients) are in TRIENTINE HYDROCHLORIDE? | TRIENTINE HYDROCHLORIDE excipients list |
| DailyMed Link: | TRIENTINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TRIENTINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Orphalan | Phase 1 |
| Alexion Pharmaceuticals | Phase 2 |
| University of Oxford | Phase 2 |
Pharmacology for TRIENTINE HYDROCHLORIDE
| Drug Class | Metal Chelator Copper Chelator |
| Mechanism of Action | Metal Chelating Activity Copper Chelating Activity |
Medical Subject Heading (MeSH) Categories for TRIENTINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TRIENTINE HYDROCHLORIDE
US Patents and Regulatory Information for TRIENTINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 212929-001 | Aug 30, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hetero Labs Ltd Iii | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 216356-001 | Jun 23, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Dr Reddys | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 211076-001 | Jul 3, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 212238-002 | Sep 22, 2023 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lupin Ltd | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 211637-001 | May 21, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 211554-001 | Apr 26, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
